The Antibiotic That Tried to Treat an Uncomplicated Diverticulum

The Claim

A person arrives with left-sided abdominal pain, and a CT scan confirms acute diverticulitis. The prescription pad comes out before the risk assessment. We have treated the word "itis" as if it were an automatic instruction to write an antibiotic. That reflex is comforting, but it is no longer a universal rule.

The July 2026 American College of Gastroenterology guideline suggests against routine antibiotics for low-risk patients with acute uncomplicated diverticulitis. The 2022 American College of Physicians guideline and the American Gastroenterological Association's expert review also support selective rather than automatic prescribing. This does not mean untreated abdominal pain is a home experiment. It means the diagnosis, risk, follow-up and exceptions deserve the attention once given to the prescription. [1] [2] [3]

What The Trials Found

The AVOD trial randomized 623 patients with CT-verified uncomplicated left-sided diverticulitis to antibiotic treatment or no antibiotics. Perforation or abscess developed in six of 309 participants without antibiotics and three of 314 given antibiotics. The difference was not statistically significant. A trial that finds no significant difference is not proof that two treatments are exactly identical, especially when serious complications are uncommon. [4]

The Dutch DIABOLO randomized trial separately compared observation with antibiotics for a first CT-confirmed episode, adding evidence that selected patients can recover without routine drug treatment. A 2022 Cochrane review of three no-antibiotic-versus-antibiotic trials involving 1,329 participants found little or no difference in short-term complications, but rated the evidence low certainty and the confidence intervals wide. The conclusion is selective restraint, not a blanket ban. [5] [6]

Why A Prescription Is Not Neutral

Antibiotics can cause adverse reactions, diarrhea, interactions and sometimes serious infections; unnecessary use also fosters resistance. Yet the failure to prescribe is not virtuous if the patient is ill, immunocompromised or developing an abscess. A rational clinician weighs two kinds of harm rather than counting prescription numbers as a measure of care. [2] [3]

The 2026 guideline says CT is especially important for confirming first presentations and assessing severe disease. In a patient whose diagnosis remains uncertain, the first decision is often about a careful examination and suitable imaging, not an antibiotic-versus-no-antibiotic slogan. [1]

The Strongest Objection

What about the one patient who deteriorates? This is the right objection. The trials enrolled selected patients; they did not license us to overlook sepsis, inability to drink, complicated disease or unreliable follow-up. Low event rates also make studies imprecise about rare catastrophes. A watchful-waiting plan needs an actual clinician, safety-net instructions and a way back if symptoms worsen. [2] [6]

The Exceptions

Antibiotics and sometimes hospitalization are appropriate when there is an abscess, perforation, obstruction, systemic illness, immunosuppression, frailty, high-risk comorbidity, prolonged or severe symptoms, vomiting, suspicious imaging or inability to ensure reliable outpatient monitoring. The AGA review specifically recommends antibiotics for immunocompromised patients. Pregnancy, diagnostic uncertainty and serious alternative abdominal conditions require individualized assessment. [1] [2] [3]

Seek emergency evaluation for severe or rapidly increasing abdominal pain, a rigid abdomen, fainting, significant bleeding, persistent vomiting, high fever with marked illness, confusion or inability to keep fluids down. These are not symptoms to manage with an online article.

What We Do About It

First, confirm the clinical picture and assess for complications. In a stable, immunocompetent person with an established diagnosis of mild uncomplicated diverticulitis and reliable follow-up, discuss observation, appropriate pain management, hydration as tolerated and a specific reassessment plan. Do not encourage patients to stop prescribed antibiotics without speaking to their treating clinician. [1] [2]

Second, make the exception list visible. Tell the patient which worsening signs should trigger immediate reassessment. Explain that recovery is an active process monitored by people, not an unattended trial of fortitude.

What Would Change The Verdict

Better randomized data in higher-risk groups showing a meaningful reduction in major complications with routine antibiotics could narrow the low-risk exception. Conversely, larger trials with reliable safety follow-up could strengthen selective use. Until then, the evidence supports judgment over reflex.

Sources and receipts

1. [1] Peery AF et al. ACG Clinical Guideline: Colonic Diverticulitis. American Journal of Gastroenterology. July 2026. — Source cited in the reviewed article
2. [2] American College of Physicians. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline. Annals of Internal Medicine. 2022. — Source cited in the reviewed article
3. [3] Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021. — Source cited in the reviewed article
4. [4] Chabok A et al. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis (AVOD). British Journal of Surgery. 2012. — Source cited in the reviewed article
5. [5] Daniels L et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis (DIABOLO). British Journal of Surgery. 2017. — Source cited in the reviewed article
6. [6] Dichman ML, Rosenstock SJ, Shabanzadeh DM. Antibiotics for uncomplicated diverticulitis. Cochrane Database of Systematic Reviews. 2022. — Source cited in the reviewed article